Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.40 |
| ▸ | GCGR | P47871 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | SLC37A4 | O43826 | 1/20 | 0.34 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL546994 | 0.89 | DCTPP1 (0.40) | DCTPP1GCGRALDH1A1KDM4EHPGD | |
| SCHEMBL11257903 | 0.84 | GCGR (0.38) | DCTPP1GCGRALDH1A1KDM4EHPGD | |
| SCHEMBL28356860 | 0.80 | SLC37A4 (0.42) | DCTPP1GCGRHPGDCNR2TRPV1 | |
| SCHEMBL2527585 | 0.80 | DCTPP1 (0.40) | DCTPP1GCGRALDH1A1KDM4EHPGD | |
| SCHEMBL5589592 | 0.77 | GCGR (0.46) | DCTPP1GCGRALDH1A1KDM4EHPGD | |
| SCHEMBL11241505 | 0.76 | GCGR (0.38) | DCTPP1GCGRALDH1A1KDM4EHPGD | |
| SCHEMBL11241501 | 0.76 | TTR (0.38) | DCTPP1GCGRALDH1A1KDM4EHPGD | |
| SCHEMBL547433 | 0.75 | ELANE (0.41) | ALDH1A1PTPN1CNR2TRPV1 | |
| SCHEMBL5589821 | 0.74 | DPP4 (0.45) | DCTPP1GCGRALDH1A1KDM4EHPGD | |
| SCHEMBL2143344 | 0.73 | KDM4E (0.49) | ALDH1A1KDM4EHPGDHSD17B10LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240240039-A1 | PIGMENT COMPOSITION, COLORING AGENT, AND INKJET INK | DIC CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| EP-4353788-A1 | BINDER RESIN COMPOSITION FOR AQUEOUS INK-JET INK, AQUEOUS INK-JET INK, AND PRINTED LAYER | DIC Corporation (JP) | 2024-04-17 | — | — | EP | disclosed |
| US-20240116953-A1 | PHTHALOCYANINE COMPOUND | DIC CORPORATION (JP) | 2024-04-11 | — | — | US | disclosed |
| EP-4349923-A1 | PHTHALOCYANINE COMPOUND | DIC Corporation (JP) | 2024-04-10 | — | — | EP | disclosed |
| US-20240076514-A1 | INK, INK FOR INK-JET RECORDING, PRINTED MATTER, AND METHOD FOR PRODUCING PRINTED MATTER | DIC CORPORATION (JP) | 2024-03-07 | — | — | US | disclosed |
| WO-2023149215-A1 | INKJET PRINTING INK AND METHOD FOR PRODUCING PRINTED MATTER | DIC株式会社 | 2023-08-10 | — | — | WO | disclosed |
| WO-2023120202-A1 | AQUEOUS INK COMPOSITION, INK SET, PRINTED MATTER, AND PRODUCTION METHOD FOR PRINTED MATTER | DIC株式会社 | 2023-06-29 | — | — | WO | disclosed |
| WO-2023112375-A1 | PIGMENT COMPOSITION, COLORING AGENT, AND INKJET INK | DIC株式会社 | 2023-06-22 | — | — | WO | disclosed |
| WO-2023105844-A1 | QUINACRIDONE PIGMENT, PIGMENT DISPERSION, AND AQUEOUS INKJET INK | DIC株式会社 | 2023-06-15 | — | — | WO | disclosed |
| EP-4194518-A1 | AQUEOUS PIGMENT DISPERSION FOR PRODUCING WATER-BASED INK-JET INK FOR PLASTIC SUBSTRATE, WATER-BASED INK-JET INK, AND PRINTED MATTER | DIC Corporation (JP) | 2023-06-14 | — | — | EP | disclosed |
| US-20050212884-A1 | Ink jet recording device and method for ink jet recording using the same | FUJI XEROX CO., LTD. (JP) | 2005-09-29 | — | — | US | disclosed |
| US-20050041081-A1 | Method for treating inkjet liquid, recording apparatus using the same, liquid storage tank, liquid absorber for liquid storage and liquid treatment apparatus | FUJI XEROX CO., LTD. | 2005-02-24 | — | — | US | disclosed |
| US-6755508-B2 | Image forming method, image forming apparatus, and a set of inks and liquid composition | FUJI XEROX CO., LTD. (JP) | 2004-06-29 | — | — | US | disclosed |
| US-20040114013-A1 | Inkjet ink and inkjet recording method | FUJI XEROX CO., LTD. | 2004-06-17 | — | — | US | disclosed |
| US-6620229-B2 | Optical recording media; wear resistance | FUJI XEROX CO., LTD. (JP) | 2003-09-16 | — | — | US | disclosed |
| US-20030151643-A1 | Image forming method, image forming apparatus, and a set of inks and liquid composition | FUJI XEROX CO., LTD. (JP) | 2003-08-14 | — | — | US | disclosed |
| US-6533853-B1 | Metal salt, carbon black, dispersant, superior rub resistance, can keep bleeding from occurring when color images are formed | CANON KABUSHIKI KAISHA (JP) | 2003-03-18 | — | — | US | disclosed |
| US-20030008080-A1 | INK JET RECORDING LIQUID AND INK JET RECORDING METHOD | FUJI XEROX CO., LTD. (JP) | 2003-01-09 | — | — | US | disclosed |
| EP-1085060-A2 | Aqueous ink for ink-jet recording, ink set, ink-jet recording process and bleeding reducing method | CANON KABUSHIKI KAISHA (JP) | 2001-03-21 | — | — | EP | disclosed |
| US-5977207-A | Ink jet recording ink and ink jet recording method | FUJI XEROX CO., LTD. (JP) | 1999-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116953-A1 | PHTHALOCYANINE COMPOUND | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PAH, PFKFB2 | DCTPP1 140/4885GCGR 4445/4885ALDH1A1 2214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.